A Phase 1 Dose-Escalation Study of SLV-154 in Subjects With Metastatic Solid Tumors

Condition: Breast Cancer, Endometrial Cancer, Cervical Cancer, Lung Cancer, Ovarian Cancer, Urothelial Cancer, Sarcoma, Thyroid Cancer


Go To Trial Homepage